ArticleInternational journal of clinical oncology2024

Appropriate definition of non-metastatic castration-resistant prostate cancer (nmCRPC) and optimal timing of androgen receptor signaling inhibitor (ARSI).

Kazuhiro Matsumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.